Potassium phosphate (dibasic) | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Potassium Phosphate Dibasic
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Potassium phosphate dibasic

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 12 USDMF, 1 CEP/COS, 8 NDC API, 10 Listed Suppliers, $ API Reference Price

20 API Suppliers
12 USDMF
1 CEP/COS
8 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers, 70 FDA Orange Book, 15 Europe, 12 Canada, 2 Listed Dossiers

99 FDF Dossiers
70 FDA Orange Book
15 Europe
12 Canada
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML), SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML), SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML)
SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)
SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 8 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 4 DKSH, 9 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 28 BASF, 1 Bioplus Life Sciences, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 39 Roquette, 8 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 32 Direct Compression, 32 Thickeners and Stabilizers, 31 Taste Masking, 31 Disintegrants & Superdisintegrants, 30 Parenteral, 29 Topical, 29 Controlled & Modified Release, 26 Granulation, 22 Solubilizers, 20 Chewable & Orodispersible Aids, 20 Lubricants & Glidants, 19 Film Formers & Plasticizers, 17 Co-Processed Excipients, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

95 Fillers, Diluents & Binders
50 Coating Systems & Additives
32 Direct Compression
32 Thickeners and Stabilizers
31 Taste Masking
31 Disintegrants & Superdisintegrants
30 Parenteral
29 Topical
29 Controlled & Modified Release
26 Granulation
22 Solubilizers
20 Chewable & Orodispersible Aids
20 Lubricants & Glidants
19 Film Formers & Plasticizers
17 Co-Processed Excipients
8 Emulsifying Agents
6 API Stability Enhancers
5 Empty Capsules
4 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 12 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 15 Finished Drug Prices

1 US Medicaid Prescriptions
15 Finished Drug Prices

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 3 US Exclusivities

1 US Patents
3 US Exclusivities

REF. STANDARDS & IMPURITIES

1 USP

1 USP

$ API Ref.Price (USD/KG) : 54 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1CMP DEV LLC

filter Patent Number Reset all filters

1 All

01 110632150

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12039-04-19

Product Main Page

01

CMP DEV LLC

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

PharmScience R&D

Not Confirmed

CMP DEV LLC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-19

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

US Patent Number : 10632150

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212121

Patent Use Code : U-2789

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!